GPRC5D is a promising target for MM therapy, present in MM cells but minimally in normal immune cells, correlating with poorer patient outcomes. Strategies for targeting GPRC5D include bispecific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback